# CLGN

## Overview
Calmegin (CLGN) is a gene that encodes the testis-specific chaperone protein calmegin, which is primarily localized in the endoplasmic reticulum (ER). As a calcium-binding protein, calmegin plays a pivotal role in spermatogenesis by facilitating the proper folding and assembly of glycoproteins necessary for sperm maturation and function. It is particularly involved in the heterodimerization of fertilin α and β subunits, which are crucial for sperm-egg fusion and binding to the egg's zona pellucida. The absence of calmegin results in infertility due to impaired sperm binding, underscoring its essential role in male fertility (Ikawa2001Calmegin; Ikawa1997The). Beyond its reproductive functions, CLGN expression has been implicated in various clinical conditions, including hepatocellular carcinoma and aldosterone-producing adenomas, where it may influence disease progression through its involvement in calcium signaling and protein synthesis (Itcho2020Endoplasmic; Cui2023The).

## Structure
Calmegin (CLGN) is a calcium-binding protein with a primary structure consisting of 611 amino acids, resulting in a calculated molecular mass of approximately 69 kDa (Watanabe1994Molecular). The protein features a hydrophobic NH2-terminal region indicative of a signal peptide, which is crucial for its localization to the endoplasmic reticulum (Watanabe1994Molecular). The secondary structure includes two hydrophilic regions, one centrally located and another at the COOH terminus, which contain highly conserved repetitive amino acid sequences (Watanabe1994Molecular).

Calmegin shares significant homology with calnexin and partial homology with calreticulin, both of which are endoplasmic reticulum-associated Ca2+-binding proteins (Watanabe1994Molecular). This homology suggests that calmegin may adopt a similar tertiary structure, potentially involving lectin-like domains necessary for its chaperone function in spermatogenesis (Ikawa2011Calsperin). The protein is involved in the maturation of sperm proteins, such as ADAM3, which is essential for fertilization (Ikawa2011Calsperin).

Calmegin undergoes post-translational modifications, including ubiquitylation, monomethylation, and acetylation, which are important for its function and stability (Chang2023Molecular). The protein's structure and modifications are crucial for its role in calcium homeostasis and protein synthesis within the testis (Chang2023Molecular).

## Function
Calmegin (CLGN) is a testis-specific endoplasmic reticulum (ER) chaperone protein that plays a crucial role in spermatogenesis. It is involved in the proper folding and assembly of glycoproteins within the ER, which is essential for the maturation of sperm membrane proteins (Ikawa2001Calmegin; Ikawa1997The). Calmegin specifically facilitates the heterodimerization of fertilin α and β, which are critical for sperm-egg fusion and binding to the egg's zona pellucida (Ikawa2001Calmegin). 

In the absence of calmegin, as observed in knockout mice, sperm are unable to bind to the zona pellucida, leading to infertility. This is due to the lack of proper maturation and surface presentation of fertilin subunits, highlighting calmegin's role as a chaperone in the ER (Ikawa2001Calmegin; Ikawa1997The). Calmegin also interacts with ADAM proteins, such as ADAM1A/ADAM2 and ADAM1B/ADAM2, which are necessary for the presence of ADAM3 in sperm, a protein essential for sperm-egg binding (Ikawa2011Calsperin; Yamaguchi2006Aberrant). These interactions underscore its importance in ensuring the correct folding and assembly of proteins critical for sperm function and fertility.

## Clinical Significance
Alterations in the expression of the CLGN gene, also known as calmegin, have been implicated in several clinical conditions. In hepatocellular carcinoma (HCC), CLGN expression is significantly elevated, with higher mRNA and protein levels correlating with poorer overall survival, progression-free survival, and disease-specific survival. This suggests that CLGN may contribute to HCC progression by promoting cell proliferation or inhibiting apoptosis, rather than through genetic mutations (Cui2023The).

In the context of male fertility, CLGN is crucial for sperm function. Deficiency in CLGN leads to impaired sperm binding to the zona pellucida, a critical step in fertilization, due to the mislocalization of ADAM proteins necessary for this process. This results in male sterility, highlighting CLGN's role in the proper assembly and function of sperm surface proteins (Ikawa1997The; Yamaguchi2006Aberrant).

CLGN is also upregulated in aldosterone-producing adenomas (APA), where it is associated with increased aldosterone production. This suggests a potential role in the pathogenesis of APA, possibly through its involvement in intracellular calcium signaling and protein synthesis within the endoplasmic reticulum (Itcho2020Endoplasmic).

## Interactions
Calmegin (CLGN) is a testis-specific chaperone protein that plays a crucial role in the maturation of sperm membrane proteins during spermatogenesis. It functions primarily in the endoplasmic reticulum, where it facilitates the proper folding and assembly of several key proteins involved in sperm fertility. CLGN specifically interacts with the fertilin α and β subunits, which are essential for sperm-egg fusion. This interaction is critical for the heterodimerization and surface presentation of fertilin α/β on sperm, as demonstrated by the absence of these heterodimers in calmegin-deficient mice (Ikawa2001Calmegin).

CLGN also interacts with ADAM proteins, including ADAM1a, ADAM1b, ADAM2, and ADAM3. These interactions are necessary for the formation of ADAM1a/ADAM2 and ADAM1b/ADAM2 heterodimers, which are crucial for the proper localization of ADAM3 on the sperm surface. In the absence of CLGN, these heterodimers fail to form, leading to the mislocalization of ADAM3 and resulting in impaired sperm binding to the zona pellucida (Yamaguchi2006Aberrant). These interactions highlight the essential role of CLGN in ensuring the correct assembly and function of proteins necessary for sperm fertility.


## References


[1. (Chang2023Molecular) Yi-Che Chang Chien, Kristóf Madarász, Szilvia Lilla Csoma, János András Mótyán, Hsuan-Ying Huang, Gábor Méhes, and Attila Mokánszki. Molecular identification and in silico protein analysis of a novel bcor-clgn gene fusion in intrathoracic bcor-rearranged sarcoma. Cancers, 15(3):898, January 2023. URL: http://dx.doi.org/10.3390/cancers15030898, doi:10.3390/cancers15030898. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15030898)

[2. (Cui2023The) Zhongyuan Cui, Jielong Wang, Gang Chen, Dongliang Li, Bianqiao Cheng, Yanhua Lai, and Zhixian Wu. The upregulation of clgn in hepatocellular carcinoma is potentially regulated by hsa-mir-194-3p and associated with patient progression. Frontiers in Oncology, January 2023. URL: http://dx.doi.org/10.3389/fonc.2022.1081510, doi:10.3389/fonc.2022.1081510. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.1081510)

[3. (Watanabe1994Molecular) D. Watanabe, K. Yamada, Y. Nishina, Y. Tajima, U. Koshimizu, A. Nagata, and Y. Nishimune. Molecular cloning of a novel ca(2+)-binding protein (calmegin) specifically expressed during male meiotic germ cell development. Journal of Biological Chemistry, 269(10):7744–7749, March 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)37349-0, doi:10.1016/s0021-9258(17)37349-0. This article has 93 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)37349-0)

[4. (Yamaguchi2006Aberrant) Ryo Yamaguchi, Kazuo Yamagata, Masahito Ikawa, Stuart B. Moss, and Masaru Okabe. Aberrant distribution of adam3 in sperm from both angiotensin-converting enzyme (ace)- and calmegin (clgn)-deficient mice1. Biology of Reproduction, 75(5):760–766, November 2006. URL: http://dx.doi.org/10.1095/biolreprod.106.052977, doi:10.1095/biolreprod.106.052977. This article has 97 citations and is from a peer-reviewed journal.](https://doi.org/10.1095/biolreprod.106.052977)

[5. (Ikawa2001Calmegin) Masahito Ikawa, Tomoko Nakanishi, Shuichi Yamada, Ikuo Wada, Katsuya Kominami, Hiromitsu Tanaka, Masami Nozaki, Yoshitake Nishimune, and Masaru Okabe. Calmegin is required for fertilin α/β heterodimerization and sperm fertility. Developmental Biology, 240(1):254–261, December 2001. URL: http://dx.doi.org/10.1006/dbio.2001.0462, doi:10.1006/dbio.2001.0462. This article has 106 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/dbio.2001.0462)

[6. (Ikawa2011Calsperin) Masahito Ikawa, Keizo Tokuhiro, Ryo Yamaguchi, Adam M. Benham, Taku Tamura, Ikuo Wada, Yuhkoh Satouh, Naokazu Inoue, and Masaru Okabe. Calsperin is a testis-specific chaperone required for sperm fertility. Journal of Biological Chemistry, 286(7):5639–5646, February 2011. URL: http://dx.doi.org/10.1074/jbc.M110.140152, doi:10.1074/jbc.m110.140152. This article has 177 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M110.140152)

[7. (Itcho2020Endoplasmic) Kiyotaka Itcho, Kenji Oki, Celso E. Gomez-Sanchez, Elise P. Gomez-Sanchez, Haruya Ohno, Kazuhiro Kobuke, Gaku Nagano, Yoko Yoshii, Ryuta Baba, Noboru Hattori, and Masayasu Yoneda. Endoplasmic reticulum chaperone calmegin is upregulated in aldosterone-producing adenoma and associates with aldosterone production. Hypertension, 75(2):492–499, February 2020. URL: http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14062, doi:10.1161/hypertensionaha.119.14062. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/HYPERTENSIONAHA.119.14062)

[8. (Ikawa1997The) Masahito Ikawa, Ikuo Wada, Katsuya Kominami, Daisuke Watanabe, Kiyotaka Toshimori, Yoshitake Nishimune, and Masaru Okabe. The putative chaperone calmegin is required for sperm fertility. Nature, 387(6633):607–611, June 1997. URL: http://dx.doi.org/10.1038/42484, doi:10.1038/42484. This article has 225 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/42484)